Actually, it's never too late to invest. At present, A-share medicine and consumption are always the core assets with significant allocation value, so it is appropriate to start the medical and health fund. Of course, many emerging pharmaceutical companies are constantly listing in Hong Kong, creating new opportunities. For example, the theme of global healthy living in rich countries released on February 8, 65438 fully grasped the high-quality target of A+H+ China Stock Exchange, which can be said to cover global investment opportunities. Zhang Feng, the fund manager who led the team, has been deeply involved in the Hong Kong stock market for nearly 20 years. If you want to be on the safe side, you might as well refer to his outstanding performance in recent years.